CD34 and leukemia: Twenty-five years ago, Lapidot et al., described these LSCs for the first time, by showing that a subset of leukemic cells enriched in the CD34+CD38− phenotype could give rise to leukemia when transplanted in immunocompromised recipient mice [10,11].